What is the recommended dose of Ondansetron Hydrochloride (Zofran) for IV administration?

What is the recommended dose of Ondansetron Hydrochloride (Zofran) for IV administration?

• A. 2mg over 2 to 5 minutes
• B. 4mg over 2 to 5 minutes
• C. 8mg over 5 to 10 minutes
• D. 1mg over 1 to 3 minutes

Answer: (B)

The recommended dose of Ondansetron Hydrochloride (Zofran) for IV administration is 4 mg over 2 to 5 minutes. This dosing is consistent with established guidelines for the prevention of nausea and vomiting in various clinical settings, particularly in patients undergoing surgery or receiving chemotherapy. Administering 4 mg IV provides an effective therapeutic dose that has been shown to significantly reduce symptoms while maintaining a favorable safety profile. The administration time of 2 to 5 minutes allows for a steady infusion that helps minimize the potential for adverse effects, such as hypotension or other infusion-related reactions. In contrast, lower doses or different administration routes may not provide the desired antiemetic effect that 4 mg does, potentially leading to inadequate symptom control. This highlights the importance of adhering to established dosing protocols to ensure patient safety and effectiveness of the medication.

The recommended dose of Ondansetron Hydrochloride (Zofran) for IV administration is 4 mg over 2 to 5 minutes. This dosing is consistent with established guidelines for the prevention of nausea and vomiting in various clinical settings, particularly in patients undergoing surgery or receiving chemotherapy.

Administering 4 mg IV provides an effective therapeutic dose that has been shown to significantly reduce symptoms while maintaining a favorable safety profile. The administration time of 2 to 5 minutes allows for a steady infusion that helps minimize the potential for adverse effects, such as hypotension or other infusion-related reactions.

In contrast, lower doses or different administration routes may not provide the desired antiemetic effect that 4 mg does, potentially leading to inadequate symptom control. This highlights the importance of adhering to established dosing protocols to ensure patient safety and effectiveness of the medication.